Life Science Investing Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights 06 November
Life Science Investing Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid, Triggering a $25 Million Milestone Payment 04 November
